Vitro Biopharma Receives Recognition from BioInformant

Vitro Biopharma Receives Recognition from BioInformant

Coronavirus disease (COVID-19) is an emerging global pandemic that is threatening the viability of healthcare systems worldwide. The virus responsible for the disease is also known as severe acute respiratory syndrome coronavirus 2 and abbreviated as SARS-CoV-2. The...
Investigating Stem Cell Therapy for the Coronavirus COVID-19 Pandemic

Investigating Stem Cell Therapy for the Coronavirus COVID-19 Pandemic

Golden, Colorado—March 17, 2020—Vitro Diagnostics, Inc. (OTCPK: VODG), dba Vitro Biopharma reports on its therapy for the Coronavirus (COVID-19) pandemic.  Recent umbilical cord stem cell therapies in China to fight the Coronavirus are producing encouraging emergency...

Potential Stem Cell Therapy for Coronavirus Infection

Golden, Colorado—February 27, 2020—Vitro Diagnostics, Inc. (OTCPK: VODG), dba Vitro Biopharma reports on a potential therapy of Coronavirus (COVID-19) infections by stem cell transplant.  While this therapy is not a method to eradicate or cure Coronavirus, there is...